Susquehanna International Group’s Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share IBER.WS Stock Holding History

Susquehanna International Group’s Portfolio IBER.WS Stock Details IBER.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-14,683	Closed	-$25	–	14088
2022 Q4	$25	Hold	14,683	–	–	﹤0.01%	12248
2022 Q3	$1K	Buy	+14,683	New	+$1.57K	﹤0.01%	13027

Other funds holding IBER.WS

LCM

Lynwood Capital Management Toronto, Ontario, Canada $16.9M AUM 19.31% 1-Year Est. Return

Susquehanna International Group's IBER.WS Position: Q1 2023 in Review

Susquehanna International Group sold out of Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share (IBER.WS) in Q1 2023, closing a stake of 14,683 shares — an estimated $25 sold.

Susquehanna International Group first reported a position in IBER.WS in Q3 2022 and held it in 2 quarters. The position peaked at $1K in Q3 2022. 1 fund tracked by Wall St. Rank holds IBER.WS as of Q1 2023.

Susquehanna International Group reported no remaining Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position as of Q1 2023 after selling out during the quarter.
Susquehanna International Group sold 14,683 Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share shares in Q1 2023, an estimated $25.
Susquehanna International Group first reported a position in Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share in Q3 2022 and held it in 2 quarters.
Susquehanna International Group's Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position peaked at $1K in Q3 2022.
1 fund tracked by Wall St. Rank held Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share as of Q1 2023.

Based on Susquehanna International Group's 13F filing for Q1 2023, filed 16 May 2023.